FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046267905> ?p ?o ?g. }

• W2046267905 endingPage "533" @default.
• W2046267905 startingPage "526" @default.
• W2046267905 abstract "Multi-drug resistant tuberculosis (MDR-TB) and extremely drug resistant (XDR) TB are big problems in the world. We have developed novel TB therapeutic vaccines, HVJ-Envelope/HSP65 + IL-12 DNA vaccine (HSP65-vaccine), granulysin vaccine and killer specific secretory protein of 37kDa (Ksp37) vaccine.HSP65 vaccine showed strong therapeutic effect against both MDR-TB and XDR-TB in mice. Intradermal immunization of HSP65-vaccine showed stronger therapeutic effect against TB than intramuscular or subcutaneous immunization. Furthermore, the synergistic therapeutic effect was observed when the vaccine was administrated in combination with Isoniazid (INH), which is a first line drug for chemotherapy. The combination of types of vaccines (HSP65- and granulysin- vaccines) also showed synergistic therapeutic effect. In the monkey model, granulysin-vaccine prolonged the survival period after the infection of TB and long-term survival was observed in vaccine-treated group. We examined the potential of two kinds of novel DNA vaccines (Ksp37-vaccine and granulysin-vaccine). Both vaccines augmented in vivo differentiation of CTL against TB. We measured the amount of Ksp37 protein in human serum and revealed that the level of Ksp37 protein of patients with tuberculosis was lower than that of healthy volunteers. Therefore, we established Ksp37 transgenic mice as well as granulysin transgenic mice to elucidate the function of those proteins. Both transgenic mice were resistant to TB infection.These data indicate the potential of combinational therapy; the combination of two DNA vaccines or combination of DNA vaccine with antibiotic drug. Thus, it will provide a novel strategy for the treatment of MDR-TB." @default.
• W2046267905 created "2016-06-24" @default.
• W2046267905 creator A5007835031 @default.
• W2046267905 creator A5012566184 @default.
• W2046267905 creator A5015262464 @default.
• W2046267905 creator A5019502524 @default.
• W2046267905 creator A5022500366 @default.
• W2046267905 creator A5024187649 @default.
• W2046267905 creator A5024473654 @default.
• W2046267905 creator A5029104834 @default.
• W2046267905 creator A5039483486 @default.
• W2046267905 creator A5039882875 @default.
• W2046267905 creator A5043695038 @default.
• W2046267905 creator A5061599791 @default.
• W2046267905 creator A5073467906 @default.
• W2046267905 creator A5081593218 @default.
• W2046267905 creator A5088889615 @default.
• W2046267905 date "2013-03-18" @default.
• W2046267905 modified "2023-10-15" @default.
• W2046267905 title "Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy" @default.
• W2046267905 cites W1497820676 @default.
• W2046267905 cites W1551363059 @default.
• W2046267905 cites W1809041433 @default.
• W2046267905 cites W1964919085 @default.
• W2046267905 cites W1971195407 @default.
• W2046267905 cites W1980682332 @default.
• W2046267905 cites W1992452635 @default.
• W2046267905 cites W2017978743 @default.
• W2046267905 cites W2021851625 @default.
• W2046267905 cites W2024783096 @default.
• W2046267905 cites W2046256656 @default.
• W2046267905 cites W2056851671 @default.
• W2046267905 cites W2061335015 @default.
• W2046267905 cites W2066843056 @default.
• W2046267905 cites W2070546641 @default.
• W2046267905 cites W2077071820 @default.
• W2046267905 cites W2079013126 @default.
• W2046267905 cites W2111954628 @default.
• W2046267905 cites W2125049374 @default.
• W2046267905 cites W2134582553 @default.
• W2046267905 cites W2135922389 @default.
• W2046267905 cites W2140144289 @default.
• W2046267905 cites W2140410090 @default.
• W2046267905 cites W2149712962 @default.
• W2046267905 cites W2163147443 @default.
• W2046267905 cites W2163569235 @default.
• W2046267905 cites W4206657305 @default.
• W2046267905 doi "https://doi.org/10.4161/hv.23230" @default.
• W2046267905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3891708" @default.
• W2046267905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23249609" @default.
• W2046267905 hasPublicationYear "2013" @default.
• W2046267905 type Work @default.
• W2046267905 sameAs 2046267905 @default.
• W2046267905 citedByCount "17" @default.
• W2046267905 countsByYear W20462679052013 @default.
• W2046267905 countsByYear W20462679052015 @default.
• W2046267905 countsByYear W20462679052016 @default.
• W2046267905 countsByYear W20462679052018 @default.
• W2046267905 countsByYear W20462679052019 @default.
• W2046267905 countsByYear W20462679052020 @default.
• W2046267905 countsByYear W20462679052022 @default.
• W2046267905 crossrefType "journal-article" @default.
• W2046267905 hasAuthorship W2046267905A5007835031 @default.
• W2046267905 hasAuthorship W2046267905A5012566184 @default.
• W2046267905 hasAuthorship W2046267905A5015262464 @default.
• W2046267905 hasAuthorship W2046267905A5019502524 @default.
• W2046267905 hasAuthorship W2046267905A5022500366 @default.
• W2046267905 hasAuthorship W2046267905A5024187649 @default.
• W2046267905 hasAuthorship W2046267905A5024473654 @default.
• W2046267905 hasAuthorship W2046267905A5029104834 @default.
• W2046267905 hasAuthorship W2046267905A5039483486 @default.
• W2046267905 hasAuthorship W2046267905A5039882875 @default.
• W2046267905 hasAuthorship W2046267905A5043695038 @default.
• W2046267905 hasAuthorship W2046267905A5061599791 @default.
• W2046267905 hasAuthorship W2046267905A5073467906 @default.
• W2046267905 hasAuthorship W2046267905A5081593218 @default.
• W2046267905 hasAuthorship W2046267905A5088889615 @default.
• W2046267905 hasBestOaLocation W20462679051 @default.
• W2046267905 hasConcept C142724271 @default.
• W2046267905 hasConcept C147969180 @default.
• W2046267905 hasConcept C159047783 @default.
• W2046267905 hasConcept C167508917 @default.
• W2046267905 hasConcept C167672396 @default.
• W2046267905 hasConcept C203014093 @default.
• W2046267905 hasConcept C2776062744 @default.
• W2046267905 hasConcept C2777966294 @default.
• W2046267905 hasConcept C2777975735 @default.
• W2046267905 hasConcept C2779078216 @default.
• W2046267905 hasConcept C2780801004 @default.
• W2046267905 hasConcept C2781069245 @default.
• W2046267905 hasConcept C71924100 @default.
• W2046267905 hasConcept C86803240 @default.
• W2046267905 hasConcept C8891405 @default.
• W2046267905 hasConceptScore W2046267905C142724271 @default.
• W2046267905 hasConceptScore W2046267905C147969180 @default.
• W2046267905 hasConceptScore W2046267905C159047783 @default.
• W2046267905 hasConceptScore W2046267905C167508917 @default.
• W2046267905 hasConceptScore W2046267905C167672396 @default.

• next